يعرض 1 - 10 نتائج من 8,390 نتيجة بحث عن '"Hirsutism"', وقت الاستعلام: 1.42s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية

    المصدر: Meditsinskiy sovet = Medical Council; № 4 (2024); 38-46 ; Медицинский Совет; № 4 (2024); 38-46 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    العلاقة: https://www.med-sovet.pro/jour/article/view/8173/7201Test; Сухих ГТ, Прилепская ВН (ред.). Национальные критерии приемлемости методов контрацепции. М.; 2023. 270 с. Режим доступа: https://phlebounion.ru/files/uploads/News/files/2023%20TestНациональные%20критерии%20приемлемости%20контрацепции%202023.pdf?ysclid=ltsge131a7262359499.; Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH et al. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(4):1233–1257. https://doi.org/10.1210/jc.2018-00241Test.; Zorbas KA, Economopoulos KP, Vlahos NF. Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review. Arch Gynecol Obstet. 2015;292(1):37–43. https://doi.org/10.1007/s00404-015-3641-1Test.; Bedaiwy MA, Allaire C, Yong P, Alfaraj S. Medical Management of Endometriosis in Patients with Chronic Pelvic Pain. Semin Reprod Med. 2017;35(1):38–53. https://doi.org/10.1055/s-0036-1597308Test.; Practice bulletin no. 114: management of endometriosis. Obstet Gynecol. 2010;116(1):223–236. https://doi.org/10.1097/AOG.0b013e3181e8b073Test.; Rousset P, Gregory J, Rousset-Jablonski C, Hugon-Rodin J, Regnard JF, Chapron C et al. MR diagnosis of diaphragmatic endometriosis. Eur Radiol. 2016;26(11):3968–3977. https://doi.org/10.1007/s00330-016-4226-5Test.; Harada T, Kosaka S, Elliesen J, Yasuda M, Ito M, Momoeda M. Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial. Fertil Steril. 2017;108(5):798–805. https://doi.org/10.1016/j.fertnstert.2017.07.1165Test.; Olive DL. Medical therapy of endometriosis. Semin Reprod Med. 2003;21(2):209–222. https://doi.org/10.1055/s-2003-41327Test.; Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008;90(5):1583–1588. https://doi.org/10.1016/j.fertnstert.2007.08.051Test.; Guzick DS, Huang LS, Broadman BA, Nealon M, Hornstein MD. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril. 2011;95(5):1568–1573. https://doi.org/10.1016/j.fertnstert.2011.01.027Test.; Brown J, Crawford TJ, Datta S, Prentice A. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev. 2018;5(5):CD001019. https://doi.org/10.1002/14651858.CD001019.pub3Test.; Marjoribanks J, Brown J, O’Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013;2013(6):CD001396. https://doi.org/10.1002/14651858.CD001396.pub3Test.; van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013;79(7):562–575. https://doi.org/10.1055/s-0032-1327831Test.; Bedaiwy MA, Casper RF. Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain. Fertil Steril. 2006;86(1):220–222. https://doi.org/10.1016/j.fertnstert.2005.12.030Test.; de Wit AE, de Vries YA, de Boer MK, Scheper C, Fokkema A, Janssen CAH et al. Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials. Am J Obstet Gynecol. 2021;225(6):624–633. https://doi.org/10.1016/j.ajog.2021.06.090Test.; Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception. 2005;72(6):414–421. https://doi.org/10.1016/j.contraception.2005.08.021Test.; Рухляда НН. Доказательная медицина и модель алгоритма выбора гормонального контрацептивного препарата. Акушерство и гинекология. 2016;(4):107–111. https://doi.org/10.18565/aig.2016.4.107-111Test.; Кузнецова ИВ. Выбор комбинированной оральной контрацепции для подростков и молодых женщин. Акушерство и гинекология. 2018;(1):35–40. https://doi.org/10.18565/aig.2018.1.35-40Test.; Хаджиева НХ, Кузнецова ИВ. Возможности КОК-ДРСП у женщин со стресс-зависимыми нарушениями менструального цикла. Медицинский алфавит. 2021;(26):23–27. https://doi.org/10.33667/2078-5631-2021-26-23-27Test.; Геворкян МА, Манухин ИБ, Кузнецов МИ, Смирнова СО. Контрацептивные и лечебные эффекты дроспиренонсодержащего гормонального контрацептива с режимом 24/4. Гинекология. 2013;15(3):14–16. Режим доступа: https://gynecology.orscience.ru/2079-5831/article/view/28196Test.; Skovlund CW, Mørch LS, Kessing LV, Lidegaard Ø. Association of Hormonal Contraception With Depression. JAMA Psychiatry. 2016;73(11):1154–1162. https://doi.org/10.1001/jamapsychiatry.2016.2387Test.; Lopez LM, Kaptein A, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2008;(1):CD006586. https://doi.org/10.1002/14651858.CD006586.pub2Test.; Eisenlohr-Moul TA, Girdler SS, Johnson JL, Schmidt PJ, Rubinow DR. Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three-arm randomized controlled trial. Depress Anxiety. 2017;34(10):908–917. https://doi.org/10.1002/da.22673Test.; Freeman EW, Halbreich U, Grubb GS, Rapkin AJ, Skouby SO, Smith L et al. An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception. 2012;85(5):437–445. https://doi.org/10.1016/j.contraception.2011.09.010Test.; Barbieri R, Chang J. Management of hirsutism in premenopausal women. UpToDate®, Wolters Kluwer; 2023. Available at: https://www.uptodate.com/contents/management-ofTest-hirsutism-in-premenopausal-women/print.; Cosma M, Swiglo BA, Flynn DN, Kurtz DM, Labella ML, Mullan RJ et al. Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab. 2008;93(4):1135–1142. https://doi.org/10.1210/jc.2007-2429Test.; Barrionuevo P, Nabhan M, Altayar O, Wang Z, Erwin PJ, Asi N et al. Treatment Options for Hirsutism: A Systematic Review and Network MetaAnalysis. J Clin Endocrinol Metab. 2018;103(4):1258–1264. https://doi.org/10.1210/jc.2017-02052Test.; Zimmerman Y, Eijkemans MJ, Coelingh Bennink HJ, Blankenstein MA, Fauser BC. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(1):76–105. https://doi.org/10.1093/humupd/dmt038Test.; Ezeh U, Huang A, Landay M, Azziz R. Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome. J Womens Health (Larchmt). 2018;27(7):892–902. https://doi.org/10.1089/jwh.2017.6833Test.; Корсак СВ, Долгушина НВ, Корнеева ИЕ, Колода ЮА, Смирнова АА, Аншина МБ и др. Женское бесплодие: клинические рекомендации. 2021. Режим доступа: https://moniiag.ru/wp-content/uploads/2019/07/Klinicheskie-rekomendatsii.-ZHenskoe-besplodie.pdfTest.; https://www.med-sovet.pro/jour/article/view/8173Test

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية